Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
SymbolNYSE:CHE
CUSIP16359R10
Phone513-762-6690
Debt
Debt-to-Equity Ratio0.19
Current Ratio1.04
Quick Ratio1.01
Price-To-Earnings
Trailing P/E Ratio56.34
Forward P/E Ratio27.04
P/E Growth2.81
Sales & Book Value
Annual Sales$1.67 billion
Price / Sales2.91
Cash Flow$7.6720 per share
Price / Cash39.27
Book Value$33.84 per share
Price / Book8.90
Profitability
EPS (Most Recent Fiscal Year)$5.36
Net Income$98.17 million
Net Margins11.00%
Return on Equity33.57%
Return on Assets19.11%
Miscellaneous
Employees14,813
Outstanding Shares16,090,000
Market Cap$5.04 billion
Chemed (NYSE:CHE) Frequently Asked Questions
What is Chemed's stock symbol?
Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."
How often does Chemed pay dividends? What is the dividend yield for Chemed?
Chemed announced a quarterly dividend on Friday, August 3rd. Stockholders of record on Monday, August 13th will be paid a dividend of $0.30 per share on Friday, August 31st. This represents a $1.20 annualized dividend and a dividend yield of 0.40%. The ex-dividend date of this dividend is Friday, August 10th. This is a positive change from Chemed's previous quarterly dividend of $0.28. View Chemed's Dividend History.
How will Chemed's stock buyback program work?
Chemed announced that its Board of Directors has approved a share repurchase plan on Wednesday, March 7th 2018, which permits the company to repurchase $150,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's management believes its stock is undervalued.
How were Chemed's earnings last quarter?
Chemed Co. (NYSE:CHE) issued its quarterly earnings data on Wednesday, July, 25th. The company reported $2.81 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.77 by $0.04. The company earned $441.80 million during the quarter, compared to the consensus estimate of $434.28 million. Chemed had a return on equity of 33.57% and a net margin of 11.00%. The company's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the firm posted $2.15 EPS. View Chemed's Earnings History.
When is Chemed's next earnings date?
How can I listen to Chemed's earnings call?
Chemed will be holding an earnings conference call on Tuesday, October 30th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8447432500.
What guidance has Chemed issued on next quarter's earnings?
Chemed issued an update on its FY18 earnings guidance on Wednesday, July, 25th. The company provided EPS guidance of $11.35-11.55 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $11.16.
What price target have analysts set for CHE?
4 brokerages have issued 1-year price objectives for Chemed's shares. Their forecasts range from $275.00 to $390.00. On average, they expect Chemed's share price to reach $328.6667 in the next year. This suggests a possible upside of 8.5% from the stock's current price. View Analyst Price Targets for Chemed.
What is the consensus analysts' recommendation for Chemed?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.
Who are some of Chemed's key competitors?
Who are Chemed's key executives?
Chemed's management team includes the folowing people:
- Kevin J. McNamara, President, Chief Executive Officer & Director
- David Patrick Williams, Chief Financial Officer & Executive Vice President
- Spencer S. Lee, Executive Vice President
- Nicholas M. Westfall, Executive Vice President
- Naomi C. Dallob, Secretary, Chief Legal Officer & Vice President
Who are Chemed's major shareholders?
Chemed's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (3.04%), MERIAN GLOBAL INVESTORS UK Ltd (1.12%), Aperio Group LLC (0.11%), Sumitomo Mitsui Asset Management Company LTD (0.07%), Denali Advisors LLC (0.04%) and Capital Insight Partners LLC (0.04%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed.
Which major investors are selling Chemed stock?
CHE stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Sumitomo Mitsui Asset Management Company LTD, Bank of Montreal Can, Capital Insight Partners LLC, Fiduciary Group LLC, Cape Cod Five Cents Savings Bank and First Citizens Bank & Trust Co.. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed.
Which major investors are buying Chemed stock?
CHE stock was acquired by a variety of institutional investors in the last quarter, including MERIAN GLOBAL INVESTORS UK Ltd, Denali Advisors LLC, Oakbrook Investments LLC, Aperio Group LLC, State of Alaska Department of Revenue, Hollencrest Capital Management, We Are One Seven LLC and Cerebellum GP LLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.
How do I buy shares of Chemed?
Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chemed's stock price today?
One share of CHE stock can currently be purchased for approximately $302.95.
How big of a company is Chemed?
Chemed has a market capitalization of $5.04 billion and generates $1.67 billion in revenue each year. The company earns $98.17 million in net income (profit) each year or $5.36 on an earnings per share basis. Chemed employs 14,813 workers across the globe.
What is Chemed's official website?
How can I contact Chemed?
Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.
MarketBeat Community Rating for Chemed (NYSE CHE)
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
